Hefei Lifeon Pharmaceutical Co., Ltd.

Hefei Lifeon Pharmaceutical Co., Ltd. saw a notable stock decline on July 17, 2026, amid ongoing performance challenges. Over the past year, the company reported a negative return, with net sales and operating profit decreasing. Its market capitalization is CNY 2,624 million, with a price-to-earnings ratio of 16.00.

Hefei Lifeon Pharmaceutical Co., Ltd. saw a notable stock price increase on July 13, 2026, amid a broader market decline. The company has shown strong short-term growth but has struggled with negative results over the past six quarters and declining net sales over five years. Its market cap is CNY 2,624 million.

Hefei Lifeon Pharmaceutical Co., Ltd. saw a notable increase in its stock today, contrasting with a decline in the broader market. The company has shown strong weekly and monthly gains, yet it faces challenges with negative results over the past six quarters and long-term underperformance.

Hefei Lifeon Pharmaceutical Co., Ltd. saw a notable stock performance today, gaining 9.12%. While the company has faced challenges with a year-to-date drop of 25.07%, it maintains a market capitalization of CNY 2,624 million and a price-to-earnings ratio of 16.00, reflecting ongoing market fluctuations.

Hefei Lifeon Pharmaceutical Co., Ltd. faced significant stock volatility, hitting an intraday low and experiencing notable declines over various time frames. The company has reported negative results for six consecutive quarters, with key financial metrics showing annual declines, raising concerns about its market position and financial health.